Publisher
Springer Science and Business Media LLC
Reference47 articles.
1. Zhu B, Jing M, Yu Q, Ge X, Yuan F, Shi L. Treatments in psoriasis: from standard pharmacotherapy to nanotechnology therapy. Adv Dermatol Allergol. 2022;39:460–71.
2. Wang K, Qi J, Weng T, Tian Z, Lu Y, Hu K, Yin Z, Wu W. Enhancement of oral bioavailability of cyclosporine A: comparison of various nanoscale drug-delivery systems. Int J Nanomed. 2014;9:4991–9.
3. Bos JD, Spuls PI. Topical treatments in psoriasis: today and tomorrow. Clin Dermatol. 2008;26:432–7.
4. Rosmarin DM, Lebwohl M, Elewski BE, Gottlieb AB. National psoriasis F. Cyclosporine and psoriasis: 2008 national psoriasis foundation consensus conference. J Am Acad Dermatol. 2010;62:838–53.
5. Lee HJ, Kim M. Challenges and future trends in the treatment of psoriasis. Int J Mol Sci. 2023;24:13313.